- Home
- HIVE vs QTRX Comparison
HIVE vs QTRX Comparison
Compare HIVE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIVE
- QTRX
- Stock Information
- Founded
- HIVE 1987
- QTRX 2007
- Country
- HIVE Canada
- QTRX United States
- Employees
- HIVE N/A
- QTRX N/A
- Industry
- HIVE
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- HIVE
- QTRX Industrials
- Exchange
- HIVE Nasdaq
- QTRX Nasdaq
- Market Cap
- HIVE 527.8M
- QTRX 439.1M
- IPO Year
- HIVE N/A
- QTRX 2017
- Fundamental
- Price
- HIVE $2.91
- QTRX $8.48
- Analyst Decision
- HIVE Strong Buy
- QTRX Strong Buy
- Analyst Count
- HIVE 6
- QTRX 4
- Target Price
- HIVE $7.42
- QTRX $23.25
- AVG Volume (30 Days)
- HIVE 11.0M
- QTRX 987.8K
- Earning Date
- HIVE 02-11-2025
- QTRX 03-17-2025
- Dividend Yield
- HIVE N/A
- QTRX N/A
- EPS Growth
- HIVE N/A
- QTRX N/A
- EPS
- HIVE N/A
- QTRX N/A
- Revenue
- HIVE $123,022,000.00
- QTRX $133,809,000.00
- Revenue This Year
- HIVE N/A
- QTRX $13.85
- Revenue Next Year
- HIVE $90.65
- QTRX $15.41
- P/E Ratio
- HIVE N/A
- QTRX N/A
- Revenue Growth
- HIVE 55.97
- QTRX 14.72
- 52 Week Low
- HIVE $2.18
- QTRX $8.21
- 52 Week High
- HIVE $5.54
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- HIVE 42.32
- QTRX 36.68
- Support Level
- HIVE $2.69
- QTRX $9.27
- Resistance Level
- HIVE $3.17
- QTRX $9.92
- Average True Range (ATR)
- HIVE 0.22
- QTRX 0.74
- MACD
- HIVE 0.01
- QTRX 0.01
- Stochastic Oscillator
- HIVE 32.89
- QTRX 28.44
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.